These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 20567964

  • 1. Effect of inhaled glucocorticoids and beta(2) agonists on vertebral fracture risk in COPD patients: the EOLO study.
    Gonnelli S, Caffarelli C, Maggi S, Guglielmi G, Siviero P, Rossi S, Crepaldi G, Nuti R, EOLO study group.
    Calcif Tissue Int; 2010 Aug; 87(2):137-43. PubMed ID: 20567964
    [Abstract] [Full Text] [Related]

  • 2. Vertebral fractures in patients with chronic obstructive pulmonary disease: the EOLO Study.
    Nuti R, Siviero P, Maggi S, Guglielmi G, Caffarelli C, Crepaldi G, Gonnelli S.
    Osteoporos Int; 2009 Jun; 20(6):989-98. PubMed ID: 18931817
    [Abstract] [Full Text] [Related]

  • 3. Inhaled glucocorticoids are associated with vertebral fractures in COPD patients.
    Gonçalves PA, Dos Santos Neves R, Neto LV, Madeira M, Guimarães FS, Mendonça LMC, Lopes AJ, Farias MLF.
    J Bone Miner Metab; 2018 Jul; 36(4):454-461. PubMed ID: 28766137
    [Abstract] [Full Text] [Related]

  • 4. Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy.
    Van Staa TP, Laan RF, Barton IP, Cohen S, Reid DM, Cooper C.
    Arthritis Rheum; 2003 Nov; 48(11):3224-9. PubMed ID: 14613287
    [Abstract] [Full Text] [Related]

  • 5. Osteoporosis risk in patients with chronic obstructive pulmonary disease: the EOLO study.
    Maggi S, Siviero P, Gonnelli S, Schiraldi C, Malavolta N, Nuti R, Crepaldi G, EOLO Study Group.
    J Clin Densitom; 2009 Nov; 12(3):345-52. PubMed ID: 19647671
    [Abstract] [Full Text] [Related]

  • 6. Osteoporosis in lung transplantation candidates with end-stage pulmonary disease.
    Shane E, Silverberg SJ, Donovan D, Papadopoulos A, Staron RB, Addesso V, Jorgesen B, McGregor C, Schulman L.
    Am J Med; 1996 Sep; 101(3):262-9. PubMed ID: 8873487
    [Abstract] [Full Text] [Related]

  • 7. Vertebral fracture and bone mineral density in women receiving high dose glucocorticoids for treatment of autoimmune diseases.
    Kumagai S, Kawano S, Atsumi T, Inokuma S, Okada Y, Kanai Y, Kaburaki J, Kameda H, Suwa A, Hagiyama H, Hirohata S, Makino H, Hashimoto H.
    J Rheumatol; 2005 May; 32(5):863-9. PubMed ID: 15868623
    [Abstract] [Full Text] [Related]

  • 8. Potential side effects in patients treated with inhaled corticosteroids and long-acting beta2-agonists.
    Korsgaard J, Ledet M.
    Respir Med; 2009 Apr; 103(4):566-73. PubMed ID: 19136239
    [Abstract] [Full Text] [Related]

  • 9. Inhaled corticosteroids and the risk of fracture in chronic obstructive pulmonary disease.
    Pujades-Rodríguez M, Smith CJ, Hubbard RB.
    QJM; 2007 Aug; 100(8):509-17. PubMed ID: 17609226
    [Abstract] [Full Text] [Related]

  • 10. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.
    Sobieraj DM, White CM, Coleman CI.
    Clin Ther; 2008 Aug; 30(8):1416-25. PubMed ID: 18803985
    [Abstract] [Full Text] [Related]

  • 11. The prevalence of osteoporosis in patients with chronic obstructive pulmonary disease: a cross sectional study.
    Jørgensen NR, Schwarz P, Holme I, Henriksen BM, Petersen LJ, Backer V.
    Respir Med; 2007 Jan; 101(1):177-85. PubMed ID: 16677808
    [Abstract] [Full Text] [Related]

  • 12. Enhanced persistence with tiotropium compared with other respiratory drugs in COPD.
    Breekveldt-Postma NS, Koerselman J, Erkens JA, Lammers JW, Herings RM.
    Respir Med; 2007 Jul; 101(7):1398-405. PubMed ID: 17368011
    [Abstract] [Full Text] [Related]

  • 13. Disc space narrowing is associated with an increased vertebral fracture risk in postmenopausal women: the OFELY Study.
    Sornay-Rendu E, Munoz F, Duboeuf F, Delmas PD, OFELY Study.
    J Bone Miner Res; 2004 Dec; 19(12):1994-9. PubMed ID: 15537442
    [Abstract] [Full Text] [Related]

  • 14. Association between corticosteroid use and vertebral fractures in older men with chronic obstructive pulmonary disease.
    McEvoy CE, Ensrud KE, Bender E, Genant HK, Yu W, Griffith JM, Niewoehner DE.
    Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):704-9. PubMed ID: 9517579
    [Abstract] [Full Text] [Related]

  • 15. [Management of osteoporosis in patients with inhaled glucocorticoids].
    Wada S, Kamiya S, Fukawa T.
    Clin Calcium; 2006 Nov; 16(11):1871-77. PubMed ID: 17079855
    [Abstract] [Full Text] [Related]

  • 16. Mono- and combination therapy of long-acting bronchodilators and inhaled corticosteroids in advanced COPD.
    Ohar JA, Donohue JF.
    Semin Respir Crit Care Med; 2010 Jun; 31(3):321-33. PubMed ID: 20496301
    [Abstract] [Full Text] [Related]

  • 17. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.
    Baker WL, Baker EL, Coleman CI.
    Pharmacotherapy; 2009 Aug; 29(8):891-905. PubMed ID: 19637942
    [Abstract] [Full Text] [Related]

  • 18. Effects of inhaled corticosteroids in monotherapy or combined with long-acting {beta}2-agonists on mortality among patients with chronic obstructive pulmonary disease.
    Cyr MC, Beauchesne MF, Lemière C, Aaron SD, Blais L.
    Ann Pharmacother; 2010 Apr; 44(4):613-22. PubMed ID: 20233915
    [Abstract] [Full Text] [Related]

  • 19. Inhaled corticosteroids are more effective in COPD patients when used with LABA than with SABA.
    Kiri VA, Bettoncelli G, Testi R, Viegi G.
    Respir Med; 2005 Sep; 99(9):1115-24. PubMed ID: 15921904
    [Abstract] [Full Text] [Related]

  • 20. Prevalence of vertebral fractures among patients with chronic obstructive pulmonary disease in Canada.
    Papaioannou A, Parkinson W, Ferko N, Probyn L, Ioannidis G, Jurriaans E, Cox G, Cook RJ, Kumbhare D, Adachi JD.
    Osteoporos Int; 2003 Nov; 14(11):913-7. PubMed ID: 14551675
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.